Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatropin growth response study in short children with growth-retarding diseases
2004-005223-18Phase 2Completed
- Sponsor
- Kinderklinik Erlangen
- Start
- Mar 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of somatropin in growth disorder, sponsored by Kinderklinik Erlangen. Primary endpoint: Increase in height standard deviation score. Started Mar 2005; status: completed.
02
Drugs
somatropin
03
Conditions
growth disorder
Beyond the preview
Go deeper on 2004-005223-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005223-18.